You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • CD25-targeted antibody–drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity

Article metrics

Article menu

Download PDFPDF

XML
Basic tumor immunology
Original research
CD25-targeted antibody–drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity

 

Online download statistics by month:

Online download statistics by month: September 2020 to March 2024

AbstractFullPdf
Sep 2020593593242
Oct 2020563563147
Nov 202029329384
Dec 202013513558
Jan 202114714763
Feb 202115015045
Mar 202113713754
Apr 202115215259
May 202111111151
Jun 202113813863
Jul 202110110137
Aug 202111011043
Sep 202115415456
Oct 202113713787
Nov 202113713770
Dec 2021979733
Jan 202215616148
Feb 202211712262
Mar 202211511666
Apr 202214815661
May 202213613652
Jun 202211611838
Jul 2022879135
Aug 20229710037
Sep 202211611788
Oct 2022777928
Nov 202214514563
Dec 2022889035
Jan 2023666637
Feb 202310811229
Mar 2023919538
Apr 2023969731
May 2023868634
Jun 2023565630
Jul 2023999945
Aug 2023878725
Sep 2023444428
Oct 2023515125
Nov 2023666629
Dec 2023808028
Jan 2024878832
Feb 2024737339
Mar 2024818157
Total572457672312